Northern Europe vs Oman: Proportion of the target population who received a 3rd dose of
Northern Europe
89.0%
in 2024
Oman
99.0%
in 2024
Northern Europe rank
2nd
Oman rank
1st
Proportion of the target population who received a 3rd dose of over time
- Northern Europe
- Oman
How they compare
Oman currently reports 99.0% against 89.0% in Northern Europe, a difference of 10.0%.
That makes Oman's figure about 1.1 times Northern Europe's.
Across all 16 years both countries report, Oman has been ahead every year.
Northern Europe ranks 2nd and Oman ranks 1st of 37 groups.
Oman has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Northern Europe | Oman | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 18.0% | 96.0% | 78.0% | Oman |
| 2010s | 89.1% | 98.8% | 9.7% | Oman |
| 2020s | 89.4% | 98.6% | 9.2% | Oman |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Northern Europe or Oman?
- Oman, at 99.0% against 89.0% in Northern Europe as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Northern Europe and Oman?
- 10.0%, with Oman ahead.
- How many years of comparable data are there for Northern Europe and Oman?
- 16 years are reported by both, from 2009 to 2024.
- How do Northern Europe and Oman rank globally for proportion of the target population who received a 3rd dose of?
- Northern Europe ranks 2nd and Oman ranks 1st of 37 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.